Danish Novo Nordisk launched its blockbuster treatment injection Ozempic in three forms in 0.25 mg, 0.5 mg and 1 mg in the ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

A medical expert warned of the side effects of the newly launched weight loss drug and advised that the drug should be taken ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week as it targets a fast-growing ...

Ozempic, a GLP-1 receptor agonist, has officially launched in India, offering a new treatment option for type 2 diabetes.

Ozempic is finally here — but it doesn’t come cheap. With costs touching ₹11,000 a month and generics still a year away, here ...

Ozempic (injectable semaglutide) is a once-weekly treatment indicated as an add-on to diet and exercise for adults with uncontrolled Type 2 diabetes mellitus (T2DM).

Ozempic, launched by Novo Nordisk in India at $24.35 weekly, aims to tap into the growing diabetes and obesity market. Despite competition looming with patent expiration next year, the company ...

Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs ...

Ozempic can be beneficial for a lot of people, however, some people should avoid it. Read on to know why the drug is not for ...

Novo Nordisk launches Ozempic in India, a type 2 diabetes treatment with weight-loss benefits, starting at ₹2,200 per week.

Danish pharma major Novo Nordisk on December 12, launched its blockbuster type 2 diabetes treatment injection Ozempic, ...